Cervical cancer is the second most commonly diagnosed cancer and the third leading cause
of cancer death among females in less developed countries. There were an estimated 527 …

Cervical cancer is the third most common cancer in women, with an estimated 529828 new
cases and 275128 deaths reported worldwide in 2008. More than 85% of the global burden …

The crude incidence of cervical cancer in the European Union is 13.2/100 000 and the crude
mortality rate is 5.9/100 000 women/year. Nearly 500 000 cervical cancer new cases are …

Cervical cancer prevention requires a multipronged approach involving primary, secondary
and tertiary prevention. The key element under primary prevention is human papilloma virus …

Cervical cancer is the commonest cancer cause of death among women in developing
countries and efforts to prevent the disease using newer approaches and HPV vaccination …

Following the demonstration of the superior validity of human papillomavirus (HPV) tests in
screening for cervical cancer and the arrival of highly efficacious HPV 16 and 18 vaccines …

Organized and opportunistic screening programs for cervical cancer have been very
successful in many developed countries with reductions in squamous cell cervical cancer …

Cytologic screening has greatly reduced the incidence of invasive cervical cancer in many
industrialized nations. State-of-the-art cervical cancer prevention is costly, however, and …

Abstract In 2018, the European Society of Gynecological Oncology (ESGO) jointly with the
European Society for Radiotherapy and Oncology (ESTRO) and the European Society of …

The EUROGIN 2011 roadmap reviews the current burden of human papillomavirus (HPV)‐
related morbidity, as well as the evidence and potential practice recommendations …